Leerink Partners analyst Mani Foroohar raised the price target on Beam Therapeutics Inc (NASDAQ: BEAM) to $47.00 (from $42.00) while ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE